The statistical tests indicated that the CD274 gene expression showed significant differences when the samples were stratified by stage (rank test P < 0.05); thus, the CD274 expression level in the advanced tumor samples was significantly decreased compared to that in the early tumor samples (Figure 6(a)–6(c)). The gene discussed is CD274; the disease is neoplasm.